Manner Carrie Eglinton Orasure Technologies Inc (OSUR) insider trading activity

Manner Carrie Eglinton is President & CEO of ORASURE TECHNOLOGIES INC. Currently has a direct ownership of 1.69 Million shares of OSUR, which is worth approximately $5.71 Million. The most recent transaction as insider was on Mar 01, 2025, when has been sold 62,382 shares (Common Stock) at a price of $3.63 per share, resulting in proceeds of $226,446. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.69M

42.96% 3M change

6.68% 12M change

Total Value Held $5.71 Million

MANNER CARRIE EGLINTON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2025	SELL Payment of exercise price or tax liability	$226,446 $3.63 p/Share	62,382 Reduced 3.56%	1,688,366 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	462,414 Added 20.89%	1,750,748 Common Stock
Feb 28 2025	BUY Open market or private purchase	$100,058 $3.49 p/Share	28,670 Added 2.18%	1,288,334 Common Stock
Feb 27 2025	BUY Open market or private purchase	$247,668 $3.15 p/Share	78,625 Added 5.88%	1,259,664 Common Stock
Jun 04 2024	SELL Payment of exercise price or tax liability	$1,867,523 $4.65 p/Share	401,618 Reduced 25.38%	1,181,039 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$213,161 $7.19 p/Share	29,647 Reduced 1.84%	1,582,657 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	260,688 Added 13.92%	1,612,304 Common Stock
Jun 04 2023	SELL Payment of exercise price or tax liability	$258,716 $5.48 p/Share	47,211 Reduced 3.38%	1,351,616 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	258,065 Added 15.58%	1,398,827 Common Stock
Jun 04 2022	BUY Grant, award, or other acquisition	$5,601,141 $4.91 p/Share	1,140,762 Added 50.0%	1,140,762 Common Stock

Also insider at

DGX

QUEST DIAGNOSTICS INC Healthcare

SVP, Advanced Diagnostics

RGEN

REPLIGEN CORP Healthcare

MCE